Assessing Timed Up and Go in Parkinson's disease: Reliability and validity of Timed Up and Go Assessment of biomechanical strategies
- PMID: 28951938
- DOI: 10.2340/16501977-2254
Assessing Timed Up and Go in Parkinson's disease: Reliability and validity of Timed Up and Go Assessment of biomechanical strategies
Abstract
Objective: To investigate the measurement properties of the Timed Up and Go Assessment of Biomechanical Strategies (TUG-ABS) to determine its adequacy for use with individuals with Parkinson's disease.
Subjects: Fifty individuals with Parkinson's disease.
Design: Diagnostic accuracy.
Methods: The study investigated the following properties: reliability (inter-examiner, intra-examiner, test-retest, internal consistency and minimal detectable change), construct validity, and floor and ceiling effect.
Results: Considering the total score, the inter-examiner, test-retest and intra-examiner reliabilities were classified as excellent (0.95 ≤ intra-class correlation coefficient (ICC)≤0.99). The TUG-ABS presented excellent internal consistency (α = 0.98). The minimal detectable change was 3.82 points. The construct validity between the TUG-ABS and the Unified Parkinson's Disease Rating Scale (UPDRS) - part III was classified as moderate (ρ = -0.62). Significant, elevated and positive correlations were obtained between TUG-ABS and the Balance Evaluation System Test (BESTest)-VI (ρ = 0.72) and negative correlations between TUG-ABS and TUG (ρ = -0.78). The discriminant function obtained with the total score of TUG-ABS classified 60% of the individuals correctly with respect to the group (determined by the performance in TUG) to which they belonged. One-way analysis of variance (ANOVA) showed that TUG-ABS discriminated the individuals with Parkinson's disease in all stages according to Hoehn & Yahr. There was a ceiling effect of 22%.
Conclusion: TUG-ABS presented adequate measurement properties in individuals with Parkinson's disease.
Similar articles
-
Clinical testing of an innovative tool for the assessment of biomechanical strategies: the Timed “Up and Go” Assessment of Biomechanical Strategies (TUG-ABS) for individuals with stroke.J Rehabil Med. 2013 Mar;45(3):241-7. doi: 10.2340/16501977-1106. J Rehabil Med. 2013. PMID: 23462895
-
The reliability and validity of the L-test in people with Parkinson's disease.Physiotherapy. 2019 Mar;105(1):84-89. doi: 10.1016/j.physio.2017.11.218. Epub 2017 Dec 5. Physiotherapy. 2019. PMID: 29395266
-
Intra-Rater, Inter-Rater and Test-Retest Reliability of an Instrumented Timed Up and Go (iTUG) Test in Patients with Parkinson's Disease.PLoS One. 2016 Mar 21;11(3):e0151881. doi: 10.1371/journal.pone.0151881. eCollection 2016. PLoS One. 2016. PMID: 26999051 Free PMC article.
-
Clinimetric properties of the Timed Up and Go Test for patients with stroke: a systematic review.Top Stroke Rehabil. 2014 May-Jun;21(3):197-210. doi: 10.1310/tsr2103-197. Top Stroke Rehabil. 2014. PMID: 24985387 Review.
-
Timed "Up & Go" test in children and adolescents.Rev Paul Pediatr. 2013 Sep;31(3):377-83. doi: 10.1590/S0103-05822013000300016. Rev Paul Pediatr. 2013. PMID: 24142322 Free PMC article. Review.
Cited by
-
The Dubousset Functional Test: a reliable and valid test in early stage Parkinson's disease patients.Neurol Sci. 2024 Jul;45(7):3137-3146. doi: 10.1007/s10072-024-07359-1. Epub 2024 Feb 1. Neurol Sci. 2024. PMID: 38296881 Free PMC article.
-
Landing wise program: feasibility study protocol for Parkinson's disease.Front Med (Lausanne). 2023 Oct 17;10:1247660. doi: 10.3389/fmed.2023.1247660. eCollection 2023. Front Med (Lausanne). 2023. PMID: 37915322 Free PMC article.
-
The Rehabilitative Effect of Archery Exercise Intervention in Patients with Parkinson's Disease.Parkinsons Dis. 2023 Jun 8;2023:9175129. doi: 10.1155/2023/9175129. eCollection 2023. Parkinsons Dis. 2023. PMID: 37333719 Free PMC article.
-
A non-expensive bidimensional assessment can detect subtle alterations in gait performance in people in the early stages of Parkinson's disease.Front Neurol. 2023 Apr 19;14:1101650. doi: 10.3389/fneur.2023.1101650. eCollection 2023. Front Neurol. 2023. PMID: 37153678 Free PMC article.
-
Protocol for randomized controlled trial to evaluate the safety and feasibility of a novel helmet to deliver transcranial light emitting diodes photobiomodulation therapy to patients with Parkinson's disease.Front Neurosci. 2022 Aug 17;16:945796. doi: 10.3389/fnins.2022.945796. eCollection 2022. Front Neurosci. 2022. PMID: 36061601 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
